Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial.
medRxiv. 2021 Sep 22:2021.09.17.21263758. doi: 10.1101/2021.09.17.21263758. Preprint.
medRxiv. 2021.
PMID: 34580673
Free PMC article.
Updated.